中华皮肤科杂志 ›› 2026, Vol. 59 ›› Issue (7): 637-644.doi: 10.35541/cjd.20250492

• 论著·光皮肤病学 • 上一篇    下一篇

海姆泊芬光动力疗法治疗四肢鲜红斑痣疗效观察及安全性回顾分析

王琳琳    曹立娟    陈柳青    李东升    胡燕燕   

  1. 武汉市第一医院皮肤科  皮肤感染和免疫湖北省重点实验室,武汉  430022
  • 收稿日期:2025-09-10 修回日期:2026-05-06 发布日期:2026-07-03
  • 通讯作者: 胡燕燕 E-mail:Yanyan_Hu2011@163.com
  • 基金资助:
    中国医药卫生事业发展基金会资助项目(2024HMME-PDT-008)

Efficacy and safety of hemoporfin-mediated photodynamic therapy for port-wine stains on the extremities: a retrospective analysis

Wang Linlin, Cao Lijuan, Chen Liuqing, Li Dongsheng, Hu Yanyan   

  1. Department of Dermatology, Wuhan No.1 Hospital, Hubei Province Key Laboratory of Skin Infection and Immunity, Wuhan 430022, China
  • Received:2025-09-10 Revised:2026-05-06 Published:2026-07-03
  • Contact: Hu Yanyan E-mail:Yanyan_Hu2011@163.com
  • Supported by:
    China Health and Medical Development Foundation(2024HMME-PDT-008)

摘要: 【摘要】 目的 评估海姆泊芬光动力疗法(HMME-PDT)治疗四肢鲜红斑痣(PWS)的疗效及安全性。方法 本研究为回顾性自身对照研究。纳入2018年4月至2024年12月于武汉市第一医院皮肤科确诊为四肢PWS并接受HMME-PDT治疗的患者,患者治疗1次、2次或3次,分析疗效和不良反应。根据皮损颜色消退程度将疗效定义为基本痊愈、显效、有效和无效。采用Kruskal Wallis H检验、Mann-Whitney U检验和多元有序logistic回归分析评估治疗1次后效果的影响因素,采用Friedman M检验比较患者治疗1次、2次、3次后的疗效差异。结果 共纳入135例四肢PWS患者,年龄1 ~ 36岁,中位年龄3(2,6)岁,男性40例(29.6%),女性95例(70.4%)。135例患者中,57例患者仅完成1次PDT,44例2次,34例3次。135例治疗1次后,无效患者为69例(51.1%);女性患者疗效优于男性(Z = -2.373,P = 0.018);不同年龄间疗效差异有统计学意义, > 12岁的患者疗效较佳(Z = 10.434,P = 0.015)。对单次治疗疗效的多元有序logistic回归分析显示,粉红型疗效优于鲜红型、紫红型(均P < 0.05),大腿、上臂、前臂疗效优于手部(均P < 0.05);PWS位于肢体的伸侧或屈侧及既往治疗史不影响疗效(均P > 0.05)。完成3次治疗的34例患者中,1次治疗后有效率41.2%(14例),显效例数、基本痊愈例数均为0;2次治疗后有效率50.0%(17例),显效率17.6%(6例),基本痊愈例数0;3次治疗后有效率64.7%(22例),显效率20.6%(7例),基本痊愈率2.9%(1例);不同治疗次数后的效果差异有统计学意义(M = 37.014,P < 0.001)。135例患者完成1次治疗后,治疗区域均出现水肿及瘙痒、烧灼、疼痛感,其他不良反应包括色素沉着(57例,42.2%)、结痂(28例,20.7%)、色素减退(9例,6.7%)、水疱(7例,5.2%)、轻度凹陷性瘢痕(4例,2.9%)、感染(2例,1.5%),未观察到全身不良反应。结论 HMME-PDT治疗四肢PWS的疗效及安全性均较好。

关键词: 葡萄酒色痣, 光化学疗法, 海姆泊芬光动力疗法, 四肢, 治疗结果

Abstract: 【Abstract】 Objective To evaluate the efficacy and safety of hemoporfin-mediated photodynamic therapy (HMME-PDT) for the treatment of port-wine stains (PWS) on the extremities. Methods A retrospective self-controlled study was conducted on patients diagnosed with extremity PWS and treated with HMME-PDT in the Department of Dermatology, Wuhan No.1 Hospital from April 2018 to December 2024. All patients received 1, 2, or 3 sessions of HMME-PDT. The efficacy and adverse reactions were analyzed. Based on the degree of lesion color fading, treatment outcomes were classified as near-complete remission, marked improvement, partial improvement, and no response. The Kruskal-Wallis H test, Mann-Whitney U test, and multivariate ordinal logistic regression analysis were used to analyze factors influencing the efficacy after 1 treatment session, and the Friedman M test was used to compare the efficacy after 1, 2, and 3 treatment sessions. Results A total of 135 patients with PWS on the extremities were enrolled, aged (M [Q1,Q3]) 3 (2, 6) years (range: 1 - 36 years), including 40 males (29.6%) and 95 females (70.4%). Among the 135 patients, 57 completed only 1 session of PDT, 44 completed 2 sessions, and 34 completed 3 sessions. After a single treatment session, 69 patients (51.1%) showed no response; the efficacy in female patients was superior to that in male patients (Z = ?2.373, P = 0.018); there was a significant difference in efficacy among different age groups, with patients aged > 12 years showing better efficacy (Z = 10.434, P = 0.015). Multivariate ordinal logistic regression analysis of the efficacy after a single treatment session showed that the efficacy for pink-type PWS was superior to that for bright red-type PWS and purple-red-type PWS (both P < 0.05), and the efficacy for lesions on the thigh, upper arm, and forearm was superior to that for lesions on the hand (all P < 0.05); however, neither the location of PWS (on the extensor or flexor side of the extremity) nor prior treatment history affected the efficacy (both P > 0.05). Among the 34 patients who completed 3 treatment sessions, the response rate after a single treatment session was 41.2% (14/34), with no patients achieving marked improvement or near-complete remission; after 2 treatment sessions, the response rate was 50.0% (17/34), the marked improvement rate was 17.6% (6/34), with no patients achieving near-complete remission; after 3 treatment sessions, the response rate was 64.7% (22/34), the marked improvement rate was 20.6% (7/34), and the near-complete remission rate was 2.9% (1/34); there was a significant difference in efficacy across different treatment sessions (M = 37.014, P < 0.001). After a single treatment session, all the 135 patients presented with edema, pruritus, burning sensations, and stinging pain at the treatment sites; other adverse reactions included hyperpigmentation (57 cases, 42.2%), crusting (28 cases, 20.7%), hypopigmentation (9 cases, 6.7%), blistering (7 cases, 5.2%), mild atrophic scars (4 cases, 2.9%), and infections (2 cases, 1.5%), and no systemic adverse reactions were observed. Conclusion HMME-PDT demonstrates favorable efficacy and safety in the treatment of PWS on the extremities.

Key words: Port-wine stain, Photochemotherapy, Hemoporfin-mediated photodynamic therapy, Extremities, Treatment outcome

引用本文

王琳琳 曹立娟 陈柳青 李东升 胡燕燕. 海姆泊芬光动力疗法治疗四肢鲜红斑痣疗效观察及安全性回顾分析[J]. 中华皮肤科杂志, 2026,59(7):637-644. doi:10.35541/cjd.20250492

Wang Linlin, Cao Lijuan, Chen Liuqing, Li Dongsheng, Hu Yanyan. Efficacy and safety of hemoporfin-mediated photodynamic therapy for port-wine stains on the extremities: a retrospective analysis[J]. Chinese Journal of Dermatology, 2026, 59(7): 637-644.doi:10.35541/cjd.20250492